List of articles in "Drug" category - Page 166

LGD-3303 is a drug which acts as a selective androgen receptor modulator with good oral bioavailability. It is a selective agonist for the androgen receptor producing functional selectivity with effective […]

S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX Inc as a potential male hormonal contraceptive. It binds to the androgen receptor more strongly than older drugs […]

AC-262356 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. It acts as a partial agonist for the androgen receptor with a Ki of […]

CB-13 (SAB-378) is a cannabinoid drug which acts as a potent agonist at both the CB1 and CB2 receptors but has poor blood–brain barrier penetration and so produces only peripheral […]

Alpha-Methylserotonin α-Methylserotonin (αMS) also known as α-methyl-5-hydroxytryptamine (α-methyl-5-HT) or 5-hydroxy-α-methyltryptamine (5-HO-αMT) is a tryptamine derivative closely related to the neurotransmitter serotonin (5-HT).

Bisulepine is strong and relatively selective antihistamine (H1-antihistamine) with hypnotic antiadrenergic and very weak anticholinergic and antiserotonergic effects. Bisulepine is marketed in Czech Republic under the trademark Dithiaden in tablet […]

Pimavanserin (ACP-103) is a drug developed by Acadia Pharmaceuticals which acts as an inverse agonist on the serotonin receptor subtype 5-HT2A with 40x selectivity over 5-HT2C and no significant affinity […]

AMDA (9-Aminomethyl-910-dihydroanthracene) is an organic compound which acts as a potent and selective antagonist for the 5-HT2A receptor. It has been used to help study the shape of the 5-HT2A […]

UH-232 ((+)-UH232) is a drug which acts as a subtype selective mixed agonist-antagonist for dopamine receptors acting as a weak partial agonist at the D3 subtype and an antagonist at […]

Jimscaline (C-(456-trimethoxyindan-1-yl)methanamine) is a conformationally-restricted derivative of the cactus-derived hallucinogen mescaline which was discovered in 2006 by a team at Purdue University led by David E. Nichols. It acts as […]